(Q50848812)

23 March 2018

title

Treatment of multiple sclerosis by transplantation of neural stem cells derived from induced pluripotent stem cells. (English)

1 reference

23 March 2018

0 references

1 reference

10

1 reference

23 March 2018

Qi Zhou

11

object named as

Qi Zhou

1 reference

23 March 2018

author name string

Chao Zhang

1

1 reference

23 March 2018

Jiani Cao

2

1 reference

23 March 2018

Xiaoyan Li

3

1 reference

23 March 2018

Haoyu Xu

4

1 reference

23 March 2018

Weixu Wang

5

1 reference

23 March 2018

Libin Wang

6

1 reference

23 March 2018

Xiaoyang Zhao

7

1 reference

23 March 2018

Wei Li

8

1 reference

23 March 2018

Jianwei Jiao

9

1 reference

23 March 2018

Tongbiao Zhao

12

1 reference

23 March 2018

publication date

27 May 2016

1 reference

23 March 2018

Science in China. Series C: Life Sciences

published in

1 reference

23 March 2018

volume

59

1 reference

23 March 2018

issue

9

1 reference

23 March 2018

page(s)

950-957

1 reference

23 March 2018

https://scigraph.springernature.com/pub.10.1007/s11427-016-0114-9

exact match

0 references

cites work

Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Myelin repair and functional recovery mediated by neural cell transplantation in a mouse model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Gait analysis in normal and spinal contused mice using the TreadScan system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Cells derived from iPSC can be immunogenic - yes or no?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Genetic dissection of mouse exploratory behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Impact of induced pluripotent stem cells on the study of central nervous system disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Patient-specific pluripotent stem cells in neurological diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Stem cell therapies and regenerative medicine in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Immunomodulation by transplanted human embryonic stem cell-derived oligodendroglial progenitors in experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Understanding the roadmaps to induced pluripotency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Clinical therapy using iPSCs: hopes and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

The therapeutic plasticity of neural stem/precursor cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Intranasal Delivery of Neural Stem Cells: A CNS-specific, Non-invasive Cell-based Therapy for Experimental Autoimmune Encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Conversion of embryonic stem cells into neuroectodermal precursors in adherent monoculture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Immunogenicity of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11427-016-0114-9

Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE10821

Identifiers

DOI

10.1007/S11427-016-0114-9

1 reference

23 March 2018

release_xkgvgnwebjbh5ogrrmwpq6xuxy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xkgvgnwebjbh5ogrrmwpq6xuxy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

23 March 2018